KDR and pancreatic ductal adenocarcinoma: Silencing VEGFR2 could promote cell development and angiogenesis in mouse models of pancreatic ductal adenocarcinoma, and up‐regulation of miR‐200 leads to decreased VEGFR2 (Sureban et al., 2013).